Record annualized recurring revenue, reflecting ongoing execution of the Connect & Scale strategy Record gross margin, demonstrating continued business transformation ...

Accelerates transition from transactional to subscription and re-occurring revenue - - Launches new product innovation for Academia & Government and Life Sciences & Healthcare - - ...

Paysign's strategic focus on Plasma and Patient Affordability programs has driven significant growth. Read more to see why PAYS stock is a Buy.